Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Here’s What Happened

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLXGet Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $16.71, but opened at $16.09. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.09, with a volume of 4,499 shares traded.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on TLX. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th. UBS Group increased their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th.

View Our Latest Analysis on Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 0.4 %

The stock has a 50-day simple moving average of $17.88.

About Telix Pharmaceuticals Limited American Depositary Shares

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

See Also

Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.